Privi Speciality Chemicals Limited has informed the Exchange about Subscription towardsEquity SHare Capital in its Joint Venture Company, Prigiv Specialties Private Limited
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Privi Speciality Chemicals and its JV partner Givaudan SA (Switzerland) together infused Rs. 50 crore into their joint venture, Prigiv Specialties Private Limited, through a preferential allotment of 5 crore equity shares at Rs. 10 each on March 26, 2026. Privi contributed Rs. 25.5 crore (51% share) while Givaudan contributed Rs. 24.5 crore (49% share), maintaining the existing ownership ratio. Post-allotment, the total paid-up capital of the JV stands at Rs. 85 crore. The capital infusion is being made as per the original JV agreement dated July 29, 2021, and its amendments.
This is a proportionate capital infusion into an existing joint venture with global fragrance major Givaudan, so there is no ownership dilution for Privi shareholders. The continued investment signals long-term commitment from both partners to grow the JV business, which is a positive strategic indicator for Privi's future earnings potential from this venture.